Bill Title: Providing for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2018-03-20 - Motion to reconsider laid on the table Agreed to without objection. [HR787 Detail]

Text: Latest bill text (Engrossed) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2017 US Congress HR787 at this time.

Social Comments on US HR787